Who is sponsoring NCT06048029?

NCT06048029 is sponsored by Assiut University.

What drugs are being tested in NCT06048029?

Interventions in NCT06048029: laparscopic Cholecystectomy in children.

What condition does NCT06048029 study?

NCT06048029 studies Laparoscopic Cholecystectomy in Children.

Is NCT06048029 still recruiting?

NCT06048029 is currently status unknown. Last updated 21 September 2023.

Last reviewed 2023-09-21 · How we verify

NCT06048029

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laparoscopic Cholecystectomy in Children. Risk Factors for Conversion. A Prospective Study .

Status unknown NA Last updated 21 September 2023

What this trial tests

NA trial testing laparscopic Cholecystectomy in children in Laparoscopic Cholecystectomy in Children in 40 participants. Status unknown.

Timeline

3 December 2023

Primary endpoint
10 December 2024

10 December 2025

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	3 December 2023
Primary completion	10 December 2024
Estimated completion	10 December 2025

Drugs / interventions tested

laparscopic Cholecystectomy in children

Conditions studied

Laparoscopic Cholecystectomy in Children — all drugs for Laparoscopic Cholecystectomy in Children →

Sponsor

Assiut University

Who can join

Adults 1 to 18, any sex, with Laparoscopic Cholecystectomy in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cholecystectomy is the most common procedure in biliary surgery which may be open or laparoscopic.laparoscopic cholecystectomy is widely accepted as the gold standard technique in both adults and children .over recent years there has been a significant increase in paediatric cholecystectomies alongside a rising incidence of childhood gall stones.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06048029 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 21 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06048029.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing